Cochlear
Petahn Foo is an experienced executive in the medical device and regulatory affairs sectors, currently serving as Vice President of Global Clinical Operations at Cochlear since September 2019, where responsibilities include overseeing the development of clinical evidence for Cochlear products. Previously, Petahn Foo held the role of Vice President for Global Pipeline Strategy and Regulatory Affairs at Cochlear, focusing on regulatory approvals for a diverse range of products. Prior to Cochlear, Petahn Foo directed Regulatory Affairs Lifecycle Innovation in Asia Pacific at Johnson & Johnson, leading teams to innovate registration strategies and ensure compliance in multiple business units. Petahn Foo’s career also includes roles in quality assurance and regulatory affairs at Johnson & Johnson, a regulatory affairs managerial position at Omnicare Clinical Research, and a scientific officer role at the Therapeutic Goods Administration. Educational qualifications include a Master of Science in Infection and Immunity from the University of Sydney and a Bachelor of Applied Science in Human Biology from the University of Canberra.
Cochlear
6 followers
Hear now. And always As the global leader in implantable hearing solutions, at Cochlear (ASX: COH) we are committed to our mission to help people hear and be heard. Our story started more than four decades ago when Professor Graeme Clark pioneered the world's first multi-channel cochlear implant and created an entirely new treatment for hearing loss. Since our formation in 1981, we continue Professor Clark’s work to help people with moderate to profound hearing loss experience a life full of hearing. We have provided more than 650,000 implantable devices. Each recipient helps form a global community of millions, through families, friends, colleagues, teachers and more. And they’re not just connected to their own community — each shares a link with each other and to Professor Clark’s childhood desire to help people hear. We aim to give people the best lifelong hearing experience and access to innovative future technologies. We understand the privilege of connecting people to a life lived with hearing. And we listen, respond and move with the times – to continue to bring hearing within reach of all those who need it. That's how we live our mission every day. Our global workforce of more than 4,000 people shares a collective determination to give more people the opportunity to enjoy a life of hearing. Cochlear’s global headquarters are on the campus of Macquarie University in Sydney, Australia with regional headquarters in Asia Pacific, Europe and the Americas. Through our offices in over 180 countries we help people of all ages to hear. Social Media Terms of Use http://bit.ly/2qRMEvY